Treatment of attention deficit hyperactivity disorder in adults and children 13 years of age and over
$49 per month
To treat attention deficit hyperactivity disorder (ADHD) in adults and children 6 years of age or older
Treatment of attention deficit hyperactivity disorder in adults and children 13 years of age and over
To treat attention deficit hyperactivity disorder (ADHD) in adults and children 6 years of age or older
Most common:
More serious:
Most common:
More serious:
You should not take Mydayis if you:
You should talk to your doctor before using Mydayis if you:
Are breastfeeding or are planning to breastfeed
You should not take Adderall if you:
You should talk to your doctor before using Adderall if you:
Once daily
Once daily
100 Mydayis capsules, extended-release 12.5 mg will cost around $1,150 for 100 capsules
100 Adderall tablets, 5 mg will cost around $950
According to the National Institute on Mental Health, ADHD is one of the most common mental health disorders affecting children. Mydayis and Adderall are brand names for prescription drugs used for the treatment of attention deficit hyperactivity disorder (ADHD). They are both amphetamine products available as extended-release formulations making them long-acting drugs.
Mydayis and Adderall are both Schedule II controlled substances under the Controlled Substances Act. Schedule II substances have a high potential for substance abuse, which can lead to dependence both psychologically and physically.
Here we will explain how they work, their similarities and differences, their side effects, and more. This should provide you with the basics to better understand your options.
Mydayis is an FDA-approved (U.S. Food and Drug Administration) medication manufactured by Shire US Inc. It is a prescription medication given to adults and children aged 13 years of age and over for the treatment of ADHD.
ADHD is a condition that causes differences in brain development and activity. Common ADHD symptoms include inattention, impulsive behavior, excess energy, and difficulties with controlling emotions. It usually emerges and is diagnosed in childhood, often between the ages of 6 and 12. It can be diagnosed later in life though. ADHD can be very disruptive to your life, affecting performance at school and in the workplace, as well as interfering with your home and social life.
Mydayis contains four active ingredients; dextroamphetamine sulfate, amphetamine sulfate, dextroamphetamine saccharate, and amphetamine aspartate monohydrate. These are mixed amphetamine salts that stimulate activity in your brain.
Mydayis increases the levels of natural chemicals in your brain called neurotransmitters (norepinephrine and dopamine). These neurotransmitters stimulate brain activity, particularly in areas involved with motivation, reward, memory, and attention. This has been shown to improve attention and focus, reduce impulsivity, and alleviate other symptoms of ADHD.
Mydayis may also be used off-label to treat narcolepsy, a sleep problem that can cause extreme drowsiness during the day and sudden attacks of sleep.
Mydayis is available in extended-release capsule form, in the following doses: 12.5 mg, 25 mg, 37.5 mg, and 50 mg.
Take Mydayis with or without food once a day in the morning. Its effects will last for around 16 hours. Mydayis capsules have a triple-bead release action and contain three types of beads per capsule: 33% of the beads are immediate-release, 33% of the beads are delayed-release working at pH 5.5, and 33% of the beads are delayed-release working at pH 7.0. Mydayis releases its medication in three phases.
Adderall is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Shire US Inc. Adderall is a central nervous system stimulant medication, used to treat ADHD in children (ages 6-12), adolescents (ages 13-17), and adults. It is also approved to treat narcolepsy. It is also thought to work by increasing the concentration of dopamine and norepinephrine in the brain.
The active ingredients in Adderall are amphetamine and dextroamphetamine. Adderall can become physically addictive and cause withdrawal symptoms when stopped.
Adderall is available as an immediate-release tablet formulation, in the following doses: 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg. It is also available in the extended-release form (Adderall XR) of a capsule in the following doses: 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg.
Your daily dose will be based on your age:
For additional safety information, read the full prescribing information and medication guides. Always speak with a healthcare professional for medical advice or about any changes to your dose so they can monitor and evaluate your condition.
The most common side effects of Mydayis in clinical trials include:
More serious side effects of Mydayis include:
The most common side effects of Adderall in clinical trials include:
More serious side effects of Adderall include
These aren’t all the side effects Mydayis or Adderall can cause. You can find more details in the patient leaflet that comes with your medication. If you have any concerns about side effects, talk to your physician or pharmacist.
Mydayis can interact with other medications. These include:
Adderall can interact with other medications. These include:
Mydayis and Adderall can interact with other medications. This can change how Mydayis and Adderall and other medications work and can make side effects more likely. Tell your prescribing physician about all your drugs, including vitamins and dietary supplements.
You should not use Mydayis if you:
Talk to your doctor before using Mydayis if you:
You should not use Adderall if you:
Talk to your doctor before using Adderall if you:
If you have any concerns about Mydayis or Adderall side effects, talk to your physician, or pharmacist for medical advice. They can discuss the best treatment options with you. Also inform your healthcare provider about any medical conditions, supplements, and over-the-counter meds you are taking. You are also encouraged to report side effects to the FDA: visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.